ArticleClinical pharmacology in drug development2020

Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors.

Chirag Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.